Home > Oncology > WCLC 2019 > Letter from the Editor

Letter from the Editor

Dr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Esch
WCLC 2019

Dear Reader,

Please take the time to go through our Congress Report with highlights from this year’s IASLC World Congress of Lung Cancer, which took place from 7-9 September in Barcelona. You will see rapid growing evidence consolidating immunotherapy as the standard for most patients with Non-Small-Cell Lung Cancer – and now also with Small-Cell Lung Cancer, the first good news in decades for the latter.

There’s news in early detection and treatment tailoring, with biomarkers increasingly identified (even though the various forms of PD-L1 scoring remain today the essential ones). Patterns of resistance may be countered with targeting agents - and, who knows, in the future lung cancer patients might be efficiently treated with CAR-T cell therapy.

Our confidence in tre...

please login to read the entire article:

You need to register to read the entire article, please do so now.

Posted on